Amendment to the listing of Rituximab

Advice of an amendment to the listing of Rituximab, for use in the Highly Specialised Drugs program effective 1 August 2007.

Please note, for Rituximab, item number 9611W, solution for I.V. infusion 500 mg in 50 mL, Mabthera brand, the heading ‘Private hospital authority required’ displayed before the restriction text should read ‘Public and private hospital authority required’.